Australia Markets closed

AbbVie Inc. (ABBV)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
144.84-1.76 (-1.20%)
At close: 04:03PM EST
144.40 -0.44 (-0.30%)
Pre-market: 06:52AM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.65
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3175.91
52-week low 3134.09
50-day moving average 3158.06
200-day moving average 3149.29

Share statistics

Avg vol (3-month) 35.45M
Avg vol (10-day) 35.66M
Shares outstanding 51.77B
Implied shares outstanding 6N/A
Float 81.77B
% held by insiders 10.11%
% held by institutions 170.74%
Shares short (13 Oct 2022) 414M
Short ratio (13 Oct 2022) 42.27
Short % of float (13 Oct 2022) 40.79%
Short % of shares outstanding (13 Oct 2022) 40.79%
Shares short (prior month 14 Sept 2022) 412.95M

Dividends & splits

Forward annual dividend rate 45.64
Forward annual dividend yield 43.67%
Trailing annual dividend rate 33.66
Trailing annual dividend yield 32.50%
5-year average dividend yield 44.31
Payout ratio 476.66%
Dividend date 314 Feb 2023
Ex-dividend date 412 Oct 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 June 2022

Profitability

Profit margin 22.03%
Operating margin (ttm)33.06%

Management effectiveness

Return on assets (ttm)8.14%
Return on equity (ttm)92.71%

Income statement

Revenue (ttm)57.35B
Revenue per share (ttm)32.39
Quarterly revenue growth (yoy)4.50%
Gross profit (ttm)38.88B
EBITDA 27.17B
Net income avi to common (ttm)12.57B
Diluted EPS (ttm)2.91
Quarterly earnings growth (yoy)20.60%

Balance sheet

Total cash (mrq)9.96B
Total cash per share (mrq)5.64
Total debt (mrq)73.19B
Total debt/equity (mrq)498.28
Current ratio (mrq)0.84
Book value per share (mrq)7.41

Cash flow statement

Operating cash flow (ttm)22.92B
Levered free cash flow (ttm)18.63B